MedTech News
.................... by Andrew Celentano
Medtronic PulseSelect pulsed field ablation wins FDA approval
The FDA has approved the Medtronic (NYSE: MDT)+
PulseSelect pulsed field ablation (PFA) system, the device developer said today.
MIT engineers design a robotic replica of the heart’s right chamber
The realistic model could aid the development of better heart implants and shed light on understudied heart disorders.
Neuranics is set to launch wearable heart monitor with magnetic sensor tech
Neuranics announced today that it plans to launch a magnetic sensor development kit for monitoring the magnetic activity of the heart.
Medtronic receives CE mark for Percept RC neurostimulator for DBS
Medtronic has received CE mark for its Percept RC neurostimulator for deep brain stimulation (DBS). The smallest and thinnest device on the market, Percept RC is the a rechargeable DBS system with BrainSense sensing technology.
Omini receives patent approval for OECT based device
Omini, a medtech company developing the first multiplexed blood testing platform for personalised medicine and chronic disease management, has been given approval by European authorities of a patent for its multi-gate Organic Electro-Chemical Transistor (OECT)-based detection device comprising depolarisation electrode.
BD receives 510(k) clearance for fingerstick blood test sample collection device
The clearance positions BD and partner Babson Diagnostics to support blood collection from community sites such as pharmacies.
Scientists develop potential new drug treatment for multiple sclerosis
CAMH-led pre-clinical studies using a small molecule drug have shown promise as a potential new treatment for multiple sclerosis (MS). The results have been published in the journal Science Advances.
New cause of diabetes discovered, offering potential target for new classes of drugs to treat the disease
Researchers at Case Western Reserve University and University Hospitals have identified an enzyme that blocks insulin produced in the body—a discovery that could provide a new target to treat diabetes.